Welcome to the Starpharma Investor CentreStarpharma Holdings Limited is an Australian stock exchange listed biotechnology company with products based on its dendrimer technology platform. |
 |
Latest News & Announcements
Notice of Annual General Meeting 2023 - Clarification (ASX Announcement)
Nov 15th, 2023
Starpharma refers to its Notice of Annual General Meeting dated 27 October 2023 (Notice).
Read More
Starpharma announces new CEO, Ms Cheryl Maley (ASX Announcement)
Nov 10th, 2023
Starpharma is today pleased to announce the appointment of Ms Cheryl Maley as Chief Executive Officer (CEO) and Managing Director of Starpharma effective 8 January 2024.
Read More
Reports & Presentations
Click here for financial reports archive
Notice of Annual General Meeting 2023 - Clarification (ASX Announcement)
Nov 15th, 2023
Starpharma refers to its Notice of Annual General Meeting dated 27 October 2023 (Notice).
Read More
Starpharma to present at Bell Potter Healthcare Conference (ASX Announcement)
Nov 14th, 2023
Starpharma has been invited to present today at the Bell Potter Healthcare Conference, a virtual investor conference that showcases Australia's leading healthcare companies to institutional investors and Bell Potter’s retail network.
Read More